This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Delivered as a Hybrid Event 17-19 May 2022
Live In-Person Event: 17-19 May, Steigenberger Wiltcher's, BrusselsDigital Experience: All presentation recordings on-demand for 10 days from 24th May

Winsome Cheuug
Associate at Covington & Burling LLP

Profile

Winsome Cheung assists life sciences and technology companies to develop and commercialise their intellectual property assets. She advises on their strategic licensing and partnering transactions, and intellectual property and commercial matters throughout the entire product lifecycle.

Winsome Cheung is an associate in Covington’s life science transactions team.

She advises a broad range of clients in the life sciences and technology industries, from start-ups, venture capital investors to global pharmaceutical companies. As a former scientist, she combines her scientific understanding with her legal and commercial knowledge to help companies build value and monetise their intellectual property assets.

Winsome regularly advises on:

  • Complex partnering arrangements, including licensing, collaboration, co-development, co-promotion and other strategic arrangements.
  • Commercial agreements throughout the entire lifecycle of life sciences and technology assets, including CRO, clinical trial, manufacturing and distribution agreements.
  • Intellectual property and commercial matters in relation to corporate transactions and venture investments, including:
    • IP and commercial diligence;
    • Ancillary/transitional agreements; and
    • IP warranties, contingent consideration provisions of share purchase/asset purchase agreements.

Prior to her legal career, Winsome completed an undergraduate degree in Biochemistry and a PhD in Medicine. During her doctoral research, she discovered a novel virus-host cell interaction which led to major scientific publications, and explored commercialisation of this research.

Agenda Sessions

  • DUAL DIALOGUE In and Out Licencing of Breakthrough Technology: How to Structure the Deal

    13:10